Quarterly report · Q3
4272.TEDINET S100SQH6
Period2023-04-01 → 2023-12-31
Filed2024-02-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥149.8bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥153.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥4.1bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥19.1bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥7.5bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥21.0bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥4.2bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥21.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.9bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥15.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥351.3bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥322.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥331.4bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥91.4bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥67.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥259.9bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥255.7bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥49.6bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥17.06 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-19.68 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.62 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.57 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥17.04 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥90.6 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 73.7% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.9% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥130m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥130m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥5.9bn |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥40.9bn |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥40.7bn |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥129m |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥3.3bn |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥48.3bn |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥48.3bn |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥888m |
| jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥60.7bn |
| jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥60.7bn |
| jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥149.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥149.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥10.0bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥122m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥122m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥5.6bn |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥51.8bn |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥51.6bn |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥122m |
| jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥9.5bn |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥47.2bn |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥47.2bn |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.5bn |
| jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥54.8bn |
| jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥54.8bn |
| jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥153.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥153.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥122m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥24.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 387
| Item | Context | Value | Unit |
|---|---|---|---|
| Investment securities | CurrentQuarterInstant | 41935000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 3845000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 3971000000 | JPY |
| Other ioa | Prior1YearInstant | 5084000000 | JPY |
| Other ioa | CurrentQuarterInstant | 5402000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -54000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -54000000 | JPY |
| Investments and other assets | Prior1YearInstant | 41021000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 51254000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 136820000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 150449000000 | JPY |
| Assets | Prior1YearInstant | 322858000000 | JPY |
| Assets | CurrentQuarterInstant | 351294000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 16239000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 21329000000 | JPY |
| Short term loans payable | Prior1YearInstant | 3380000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 12666000000 | JPY |
| Current portion of bonds | Prior1YearInstant | - | JPY |
| Current portion of bonds | CurrentQuarterInstant | 8000000000 | JPY |
| Accounts payable other | Prior1YearInstant | 10662000000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 14566000000 | JPY |
| Income taxes payable | Prior1YearInstant | 2133000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 1102000000 | JPY |
| Other cl | Prior1YearInstant | 6633000000 | JPY |
| Other cl | CurrentQuarterInstant | 6830000000 | JPY |
| Current liabilities | Prior1YearInstant | 39049000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 64495000000 | JPY |
| Bonds payable | Prior1YearInstant | 8000000000 | JPY |
| Bonds payable | CurrentQuarterInstant | - | JPY |
| Long term loans payable | Prior1YearInstant | 8200000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 13500000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 395000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 408000000 | JPY |
| Other ncl | Prior1YearInstant | 12186000000 | JPY |
| Other ncl | CurrentQuarterInstant | 12979000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 28782000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 26887000000 | JPY |
| Liabilities | Prior1YearInstant | 67831000000 | JPY |
| Liabilities | CurrentQuarterInstant | 91383000000 | JPY |
| Capital stock | Prior1YearInstant | 14932000000 | JPY |
| Capital stock | CurrentQuarterInstant | 14932000000 | JPY |
| Capital surplus | Prior1YearInstant | 15803000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 15828000000 | JPY |
| Retained earnings | Prior1YearInstant | 202976000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 197929000000 | JPY |
| Treasury stock | Prior1YearInstant | -5523000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -5412000000 | JPY |
| Shareholders equity | Prior1YearInstant | 228189000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 223278000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 8023000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |